Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
CSTI-500
DRUG
2 trials
Sponsors
ConSynance Therapeutics
Conditions
Prader-Willi Syndrome
Phase 1
A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome
Completed
NCT05504395
ConSynance Therapeutics
Prader-Willi Syndrome
Start: 2022-11-14
End: 2023-02-21
Updated: 2023-08-09
Phase 2
A Study of CSTI-500 in Patients With Prader-Willi Syndrome
Recruiting
NCT07348601
ConSynance Therapeutics
Prader-Willi Syndrome
Start: 2026-05-01
End: 2027-06-01
Target: 12
Updated: 2026-05-15